Abstract:Background: An increasing amount of data are being published which risk-stratify thyroid tumors according to genetic signatures and histologic morphology. Typically, follicular patterned lesions have been shown to harbor RAS-like mutations with more indolent behaviors. Our study aims to examine the extent of similarity amongst three groups of follicular patterned lesions with papillary nuclear features--noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) with capsular and/or angioinvasion and infiltrative follicular variant of papillary thyroid carcinoma (iFVPTC)--in order to help clarify whether NIFTP and EFVPTC represent a histologic continuum and the degree to which the genomic landscape further separates higher risk follicular patterned tumors like iFVPTC from more indolent ones (EFVPTC and NIFTP). Methods: ThyroSeq test results were compared for cases with histologic NIFTP, EFVPTC and iFVPTC in this retrospective study. Genetic drivers were subcategorized by level of aggressiveness. Gene expression alterations (GEAs) and copy number alterations (CNAs) were compared amongst the three histologic groups. Results: NIFTP and EFVPTC cases displayed predominantly RAS-like alterations (100% and 75% respectively) and RAS-like GEAs (55.2% and 47.2%), and many showed CNAs with 22q-loss. Despite a predominance of RAS-like alterations, EFVPTC cases showed molecular heterogeneity with significantly more intermediate and aggressive drivers (22.3% of cases) than NIFTP (0%), p= 0.0068. iFVPTC cases displayed molecular profiles in between that of traditional follicular patterned lesions and classical papillary thyroid carcinoma, predominantly displaying intermediate and aggressive drivers (61.6%), which was significantly higher than that of EFVPTC (22.3%, p=0.0158) and NIFTP (0%, p<0.0001), illustrating the higher MAP-Kinase activity of iFVPTC. There was no significant difference however in comparing GEAs amongst the three histologic groups. Conclusions: While follicular patterned lesions with papillary nuclear features overall tend to display RAS-like alterations, EFVPTC cases, followed by iFVPTC in this series showed increasing proportions of more aggressive drivers. EFVPTC and NIFTP show much molecular overlap, with predominance of RAS-like alterations, suggesting that these tumors are part of a genetic continuum, while still ranked differentially. Preoperative molecular testing can potentially distinguish EFVPTC and iFVTPC from NIFTP based on a particular molecular signature, optimizing patient management.

Oncocytic/Hürthle cell lesions have the same implied risk of neoplasm/malignancy as their follicular counterparts

Correlation of Cytologic Features With Molecular Testing of Indeterminate Oncocytic (Hürthle Cell) Thyroid Lesions

ACR TI-RADS and ATA ultrasound classifications are helpful for the management of thyroid nodules located in the isthmus

Impact of molecular testing on detecting mimics of oncocytic neoplasms in thyroid fine-needle aspirates diagnosed as follicular neoplasm of Hürthle cell (oncocytic) type

Thyroid fine-needle aspiration cytology: malignancy rate in the category of indeterminate significant atypia/indeterminate significant follicular lesion

Comparison of fine needle aspiration and non-aspiration cytology for diagnosis of thyroid nodules: A prospective, randomized, and controlled trial

Risk stratification of ThyroSeq results in indeterminate thyroid lesions: A single‐institution experience of clinicopathologic correlation with cytologic findings

Fate of nondiagnostic thyroid fine needle aspirations

Comparison of fine needle aspiration and non-aspiration cytology techniques in 322 thyroid lesions

A case series of thyroid fine needle aspiration biopsies diagnosed as follicular neoplasm with oncocytic features

Hürthle Cells on Fine-Needle Aspiration Cytology Are Important for Risk Assessment of Focally PET/CT FDG Avid Thyroid Nodules

An attempt to reduce unnecessary surgical procedures... Can ultrasound characteristics help in differentiating adenoma vs carcinoma in follicular thyroid neoplasms?

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology

Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing

A Proposal to Stratify the Intermediate-Risk Thyroid Nodules According to the AACE/ACE/AME Guidelines with Ultrasound Features

Ultrasound-guided Fine-Needle Aspiration of Thyroid Nodules: Does the Size Limit Its Efficiency?

The Incidence of Thyroid Cancer in Bethesda III Thyroid Nodules: A Retrospective Analysis at a Single Endocrine Surgery Center

Is the nodule location a predictive risk factor for cancer in AUS/FLUS thyroid nodules? A retrospective cohort study

Beyond malignancy risk stratification: FNAC report anticipates thyroid cancer staging. Insights from recent studies

Fine Needle Aspiration is Not a Risk Factor for Cervical Lymph Node Metastasis or Prognostic Factor in Papillary Thyroid Microcarcinoma: A Propensity Score-Matched Analysis

Molecular Profiles of Non-Invasive, Minimally Invasive and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features